BD (Becton, Dickinson and Co.) (NYSE: BDX) has promoted from within for the new worldwide president of its Surgery business ...
BD's outgoing diagnostic solutions and biosciences catalog brought in about $3.4 billion in 2024 sales. It will include tests for infectious disease and cervical cancer screening, as well as flow ...
BD gains tariff support through a commitment to expand domestic medical device production.
Medical technology company Becton, Dickinson and Company (NYSE:BDX) announced better-than-expected revenue in Q1 CY2026, with sales up 5.2% year on year to $4.71 billion. Its non-GAAP profit of $2.90 ...
PRNewswire/ -- (NYSE: BDX), a leading global medical technology company, today marked 65 years of manufacturing in ...
"This is good news for Nebraska," said Sen. Ricketts. "It has the potential to bring over 100 new jobs to our state. This investment further underscores BD's ongoing commitment to keep critical ...
BD’s new company will have the freedom to expand its portfolio of tools and technologies for the chronic care of diabetes. (BD) () After nearly a century spent building out its portfolio of insulin ...
BD (Becton, Dickinson and Company) announced a landmark partnership with the U.S. Government to expand domestic manufacturing and strengthen the resilience of supply chains for essential medical ...
FRANKLIN LAKES, N.J., July 22, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Dr. Michael (Mike) Garrison has ...
(RTTNews) - Medical technology company Becton, Dickinson and Co. or BD (BDX) announced that it has selected "embecta" as the name of the independent, publicly-traded company that will hold BD's ...
Global medtech giant BD (Becton, Dickinson and Co.) announced today it has acquired Tepha Inc., a developer and manufacturer of proprietary resorbable polymer technology. Tepha's resorbable polymer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results